Gallant
PrivateLast Round
Series B
Jun 30, 2025
Total Funding Raised
$51M
Company Overview
Gallant is a biotechnology company that develops a pet health technology platform providing stem cell therapy and regenerative medicine to treat diseases in companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gallant Comparables
Compare Gallant with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StemcellX | 86% | |
| Animal Cell Therapies, Inc. | 84% | |
| VetStem Biopharma | 84% | |
Gallant Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 30, 2025 | ||||
| Series A | Jan 8, 2024 | ||||
| Seed | Oct 24, 2019 | ||||
| Seed | Aug 5, 2019 |
Gallant Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Seed |
| Maveron | Seed |
| Digitalis Ventures | Series A, Series B |
| Hill Creek Capital | Series A, Series B |
| Science Inc. | Seed |
| BOLD Capital Partners | Seed, Series B, Series A |
| NovaQuest Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 27, 2026
Partnering with MWI Animal Health for ultra-low temperature cold chain logistics.
- Sep 15, 2025
Launched GallantU, an online continuing education platform for veterinary professionals.
Gallant Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gallant's valuation, stock price, and market status.